Results 131 to 140 of about 2,361 (178)
RASopathies and Cardiac Complications: Insights into Mechanisms, Diagnosis, and Innovative Treatments. [PDF]
Garg K +6 more
europepmc +1 more source
Genetic Pigmentary Disorders: From Molecular Mechanisms to Clinical Manifestations. [PDF]
Okamura K, Suzuki T.
europepmc +1 more source
EndoCompass Project: Research Roadmap for Growth Disorders.
Gevers EF +20 more
europepmc +1 more source
Trametinib Therapy for Hypertrophic Cardiomyopathy and Pulmonary Hypertension in a Child With RAF1-Related Noonan Syndrome (p.Ser257Leu): A Case Report. [PDF]
Nilsson CN +8 more
europepmc +1 more source
The Clinical Utility of Sequence-Based Genetic Testing for Fetal Edema Following Non-Diagnostic Microarray Results: A Population-Based Cohort Study. [PDF]
Allen VM +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Endocrinological manifestations in RASopathies
American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, 2022AbstractThe evaluation of endocrine involvement in RASopathies is important for the care and follow‐up of patients affected by these conditions. Short stature is a cardinal feature of RASopathies and correlates with multiple factors. Growth hormone treatment is a therapeutic possibility to improve height and quality of life.
Andrea Pession +2 more
exaly +3 more sources

